Massalia Therapeutics secures seed financing to develop its SANF factor for treating cancer and fibrosis. The company aims to begin first-in-man trials within six months.
Round Type
Seed
MarseilleBiotechnologyHealth CareTherapeuticsInvestors
Description
Massalia Therapeutics has initiated its seed financing to develop the SANF factor, targeting conditions related to fibrosis and neoplasia. The company's preclinical program is ready for an Investigational New Drug application, intending to start human trials soon. The average cost for study registration and early testing is projected between €0.5m and €5m. The support from Landmark BioVentures and Aix-Marseille University has been crucial for the company's foundation.
Quick answer
Massalia Therapeutics raised an undisclosed amount in a Seed round, dated May 20, 2025. Investors: Landmark BioVentures and Aix Marseille University. Massalia Therapeutics is based in Marseille, Provence Alpes Côte D'azur, France.
- How much did Massalia Therapeutics raise?
- Massalia Therapeutics raised an undisclosed amount in a Seed round on May 20, 2025.
- Who invested in Massalia Therapeutics?
- Landmark BioVentures and Aix Marseille University are named as investors in this round.
- What does Massalia Therapeutics do?
- Massalia Therapeutics transforms lives by pioneering therapeutics for aggressive cancers and fibrotic diseases
- Where is Massalia Therapeutics based and how big is it?
- Massalia Therapeutics is based in Marseille, Provence Alpes Côte D'azur, France. Fundz records about 1 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Massalia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- FELIQS raised $9M (Series A) on July 1, 2025.
- Pelthos Therapeutics raised $50M on July 1, 2025.
- Gallant raised $18M (Series B) on June 30, 2025.
- NewcelX raised $1M (Seed) on June 27, 2025.
- Gallant raised $10M on June 27, 2025.
- Biofrontera raised $11M on June 27, 2025.
Who to call at Massalia Therapeutics, and when
A new round usually means Massalia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Massalia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Massalia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Massalia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Massalia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Massalia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.